Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a preclinical materials science study reporting rational design and in vitro/in vivo characterization of a nanoagent; it raises mechanistic questions about nanoparticle performance but does not test efficacy against a comparator in any clinical or disease model.
This is an unrefereed arXiv preprint describing a computer science methodology for GNN model ownership verification; it has not undergone peer review and reports no clinical or human trial data.
A structured synthesis of expert consensus, guidelines, and evidence summaries on nutritional management across the bladder cancer care pathway, designed to inform clinical practice.
Single-arm phase 2 trial with encouraging response and survival outcomes in ES-SCLC, but lacks a comparator arm and requires phase 3 validation to establish practice-changing impact.
This is an unrefereed preprint presenting a novel algorithmic framework with theoretical analysis and experimental validation, but lacking peer review and clinical or established-domain validation.